| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2002-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262baf90be0fb5d6ad81e04f35056b20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed58adac2116f93d9bae1b41aa5932e |
| publicationDate |
2005-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-531346-A |
| titleOfInvention |
Medicinal compositions containing angiotensin II receptor antagonist |
| abstract |
A pharmaceutical composition comprising as active ingredients an angiotensin II receptor antagonist and an ACAT inhibitor is disclosed, wherein the composition is in a form suitable for separate or sequential administration of an angiotensin II receptor antagonist and an ACAT inhibitor as the active ingredients. These pharmaceutical compositions are suitable for the prevention or treatment of ischemic heart disease, ischemic brain disease or peripheral circulatory failure in a warm blooded animal. |
| priorityDate |
2001-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |